Life Scientist > Biotechnology

Pharmaxis concludes Brochitol trial

13 June, 2008 by Dylan Bushell-Embling

Pharmaxis to file marketing application pending publication


Genepharm into its Strides

13 June, 2008 by Dylan Bushell-Embling

Genepharm shareholders to vote on Strides business next week


Correction: LabTech launches MicroStreak in US

13 June, 2008 by ALS staff

Incorrect figures provided


Circadian changes direction

12 June, 2008 by Dylan Bushell-Embling

Circadian moves from 'biotech incubator' to drug development company


Optiscan live with FIVE 1

12 June, 2008 by Dylan Bushell-Embling

Optiscan recruiting distributors in US, Europe and Asia for microscopes


The mail on catfish

11 June, 2008 by Staff Writers

New fish species named after veteran US postman


Clinuvel gets green light

11 June, 2008 by Dylan Bushell-Embling

Ethical approval granted for stage II testing of photo-receptive drug


Overture to continue

11 June, 2008 by Kate McDonald

Ovarian cancer trial to continue recruitment.


LabTech launches MicroStreak in US

11 June, 2008 by Dylan Bushell-Embling

Technology launched in US market after successful European debut


Apollo signs $500,000 deal with Symansis

11 June, 2008 by Dylan Bushell-Embling

Includes the sale of assets and licensing of proprietary techniques


ChemGenex acquires leukaemia drug outright

11 June, 2008 by Dylan Bushell-Embling

Large stock trade to take place of royalty payments


Court approves pSvida re-incorporation

11 June, 2008 by Dylan Bushell-Embling

Re-lists on NASDAQ, temporary halt on ASX


Director of Resmed board resigns

10 June, 2008 by Dylan Bushell-Embling

Farrell to continue as executive director


Pharmaust finds buyer for CBI

10 June, 2008 by Dylan Bushell-Embling

Terms to be voted on in July


pSvida to list on Nasdaq

10 June, 2008 by Dylan Bushell-Embling

Shareholders agree to re-incorporation on US stock exchange


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd